UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

Genetics in medicine, 2016-08, Vol.18 (8), p.823-832

2016

Volltextzugriff (PDF)

Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers

JAMA oncology, 2019-09, Vol.5 (9), p.1325

2019

Volltextzugriff (PDF)

MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer

Genetics in medicine, 2018-10, Vol.20 (10), p.1167-1174

2018

Volltextzugriff (PDF)

Age-adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls

Hereditary cancer in clinical practice, 2019-07, Vol.17 (1), p.19-19, Article 19

2019

Volltextzugriff (PDF)

Germline pathogenic variants identified in women with ovarian tumors

Gynecologic oncology, 2018-12, Vol.151 (3), p.481-488

2018

Volltextzugriff (PDF)

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Clinical cancer research, 2022-09, Vol.28 (17), p.3742-3751

2022

Volltextzugriff (PDF)

Phenotypic continuum between POLE‐related recessive disorders: A case report and literature review

American journal of medical genetics. Part A, 2022-10, Vol.188 (10), p.3121-3125

2022

Volltextzugriff (PDF)

Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

Cancer research (Chicago, Ill.), 2023-08, Vol.83 (15), p.2557-2571

2023

Volltextzugriff (PDF)

Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer

Familial cancer, 2022-10, Vol.21 (4), p.415-422

2022

Volltextzugriff (PDF)

Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels

Cancer genetics, 2022-08, Vol.266-267, p.86-89

2022

Volltextzugriff (PDF)

Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis

Familial cancer, 2019-04, Vol.18 (2), p.203-209

2019

Volltextzugriff (PDF)

Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis

Annals of surgical oncology, 2018-11, Vol.25 (12), p.3556-3562

2018

Volltextzugriff (PDF)

Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing

Cancer genetics, 2020-08, Vol.246-247, p.12-17

2020

Volltextzugriff (PDF)

Ancestry‐specific hereditary cancer panel yields: Moving toward more personalized risk assessment

Journal of genetic counseling, 2020-08, Vol.29 (4), p.598-606

2020

Volltextzugriff (PDF)

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

International Journal of Breast Cancer, 2011-01, Vol.2011 (2011), p.145-153

2011

Volltextzugriff (PDF)

Teachers' Perceptions of Teasing in Schools

Journal of school violence, 2010-01, Vol.9 (1), p.2-22

2010

Volltextzugriff (PDF)

Teacher Responses to Bullying: Self-Reports from the Front Line

Journal of school violence, 2009-04, Vol.8 (2), p.136-158

2009

Volltextzugriff (PDF)

PD35-07 PROSTATE CANCER RISKS IN MALE BRCA1/2 PATHOGENIC VARIANT CARRIERS

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Volltextzugriff (PDF)

Using a Participatory Culture-Specific Intervention Model to Develop a Peer Victimization Intervention

Journal of applied school psychology, 2006-10, Vol.22 (2), p.35-57

2006

Volltextzugriff (PDF)

High prevalence of pathogenic variants in individuals with colorectal cancer ≤ age 35

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.576-576

2018

Volltextzugriff (PDF)

Multigene hereditary cancer testing in sarcoma patients

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1518-1518

2017

Volltextzugriff (PDF)

Germline pathogenic variants in patients with pheochromocytoma

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.668-668

2018

Volltextzugriff (PDF)

Polyp burden in Lynch syndrome patients ascertained via multigene panel testing

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.596-596

2018

Volltextzugriff (PDF)

Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1580-1580

2018

Volltextzugriff (PDF)

Multigene hereditary cancer panel testing for patients with pancreatic cancer

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.244-244

2017

Volltextzugriff (PDF)

1 – 25 von 181

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(154)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(181)

Erscheinungsjahr

n.n

Thema

Science & Technology
(128)
Life Sciences & Biomedicine
(108)
Humans
(74)
Female
(48)
Male
(33)
Middle Aged
(29)
Adult
(27)
Aged
(21)
Animals
(16)
Oncology
(16)
Physical Sciences
(14)
General & Internal Medicine
(13)
Adolescent
(12)
Biological And Medical Sciences
(12)
Social Sciences
(12)
Pediatrics
(11)
Public, Environmental & Occupational Health
(11)
Medical Sciences
(10)
Medicine, General & Internal
(10)
United States
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

Comparison of CDH1 Penetrance Estimates in Clinically Ascertained Families vs Families Ascertained for Multiple Gastric Cancers

MSH6 and PMS2 germ-line pathogenic variants implicated in Lynch syndrome are associated with breast cancer

Age-adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls

Germline pathogenic variants identified in women with ovarian tumors

Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay

Phenotypic continuum between POLE‐related recessive disorders: A case report and literature review

Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C

Monoallelic MUTYH pathogenic variants ascertained via multi-gene hereditary cancer panels are not associated with colorectal, endometrial, or breast cancer

Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels

Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis

Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis

Differences in cancer prevalence among CHEK2 carriers identified via multi-gene panel testing

Ancestry‐specific hereditary cancer panel yields: Moving toward more personalized risk assessment

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

Teachers' Perceptions of Teasing in Schools

Teacher Responses to Bullying: Self-Reports from the Front Line

PD35-07 PROSTATE CANCER RISKS IN MALE BRCA1/2 PATHOGENIC VARIANT CARRIERS

Using a Participatory Culture-Specific Intervention Model to Develop a Peer Victimization Intervention

High prevalence of pathogenic variants in individuals with colorectal cancer ≤ age 35

Multigene hereditary cancer testing in sarcoma patients

Germline pathogenic variants in patients with pheochromocytoma

Polyp burden in Lynch syndrome patients ascertained via multigene panel testing

Mosaic TP53 pathogenic variants on multi-gene hereditary cancer panel testing: Clinical characteristics and follow-up testing

Multigene hereditary cancer panel testing for patients with pancreatic cancer

Suchergebnisse filtern